Guanning Shang

Guanning Shang

Auto-generated profile, based on publicly available information

Guanning Shang

Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2022 in Seminars in Cell & Developmental Biology
Verified
Journal Article
Closed access
TCTing Chen
Ting Chen
JLJinxin Liu
Jinxin Liu
SLShizhe Li
Shizhe Li
PWPeter Wang
Peter Wang
GSGuanning Shang
Guanning Shang

4 July 2019 in Oncology Letters
Verified
Journal Article
Open access
PDF file
YPYi Pei
Yi Pei
YZYueyan Zhang
Yueyan Zhang
KZKe Zheng
Ke Zheng
GSGuanning Shang
Guanning Shang
Yu-Ming WangYu-Ming Wang
Yu-Ming Wang
XZXiaojing Zhang
Xiaojing Zhang
Osteosarcoma is a highly malignant tumour that occurs in adolescents. Upregulation or the constitutive activation of epidermal growth factor receptor (EGFR) is a hallmark of osteosarcoma. To investigate the effect of ursolic acid on the biological function of osteosarcoma, MTT assay was used to detect the effect of ursolic acid on the proliferation of HOS and MG63 cells, while flow cytometry was used to analyse the effect on the cell cycle and apoptosis. Transwell and Matrigel assays were used to detect the effect of ursolic acid on cell migration and invasion, respectively. Western blot analysis and reverse transcription‑quantitative polymerase chain reaction were used to detect the effects of different concentrations of ursolic acid on EGFR signaling pathway‑related proteins, cell cycle, apoptosis and cell migration‑related proteins. After overexpression or silencing of EGFR, the effects of ursolic acid on EGFR pathway and cell biological function were subsequently detected, using the same methods. The present study identified that ursolic acid had inhibitory effects on the growth and metastatic ability of osteosarcoma cells by suppressing EGFR.